Cargando…
Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background
Primary plasma cell leukemia (pPCL) is a highly aggressive plasma cell dyscrasia characterised by short remissions and very poor survival. Although the 17p deletion is associated with poor outcome and extramedullary disease in MM, its presence does not confer the degree of aggressiveness observed in...
Autores principales: | Rojas, Elizabeta A., Corchete, Luis A., Mateos, María Victoria, García-Sanz, Ramón, Misiewicz-Krzeminska, Irena, Gutiérrez, Norma C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868169/ https://www.ncbi.nlm.nih.gov/pubmed/31748515 http://dx.doi.org/10.1038/s41408-019-0253-1 |
Ejemplares similares
-
Factors Regulating microRNA Expression and Function in Multiple Myeloma
por: Misiewicz-Krzeminska, Irena, et al.
Publicado: (2019) -
A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: biological and clinical utility
por: Misiewicz-Krzeminska, Irena, et al.
Publicado: (2018) -
Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma
por: Herrero, Ana B., et al.
Publicado: (2016) -
DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma
por: Quwaider, Dalia, et al.
Publicado: (2017) -
Expression of p53 protein isoforms predicts survival in patients with multiple myeloma
por: Rojas, Elizabeta A., et al.
Publicado: (2022)